James M. Mock serves as Executive at PERKINELMER INC, where they oversee executive responsibilities. Since joining the company, James M. Mock has executed 64 insider transactions totaling $3.5M, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 5, 2025 involved selling 22,817 shares valued at $581.6K.
James M. Mock currently holds 43,200 shares of PERKINELMER INC (PKI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James M. Mock has been a net seller of PKI stock. They have purchased $0 and sold $3.5M worth of shares.
James M. Mock's most recent insider trade was on Dec 5, 2025, when they sold 22,817 shares at $25.49 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Nov 28, 2025 | MRNA | $0 | Option Exercise | 329 | $N/A | Discretionary |
| Nov 28, 2025 | MRNA | $4.0K | Payment | 160 | $25.01 | Discretionary |
| Nov 26, 2025 | MRNA | $9.3K | Payment | 374 | $24.75 | Discretionary |
| Nov 26, 2025 | MRNA | $0 | Option Exercise | 773 | $N/A | Discretionary |
| Oct 3, 2025 | MRNA | $0 | Option Exercise | 1,453 | $N/A | Discretionary |
| Oct 3, 2025 | MRNA | $19.9K | Payment | 703 | $28.37 | Discretionary |
| Aug 28, 2025 | MRNA | $4.0K | Payment | 160 | $25.10 | Discretionary |
| Aug 28, 2025 | MRNA | $0 | Option Exercise | 329 | $N/A | Discretionary |
| Aug 27, 2025 | MRNA | $9.3K | Payment | 375 | $24.73 | Discretionary |
| Aug 27, 2025 | MRNA | $0 | Option Exercise | 774 | $N/A | Discretionary |
| Jul 3, 2025 | MRNA | $21.3K | Payment | 703 | $30.28 | Discretionary |
| Jul 3, 2025 | MRNA | $0 | Option Exercise | 1,453 | $N/A | Discretionary |
| Aug 29, 2024 | MRNA | $12.6K | Sale | 162 | $78.03 | Planned |
| Aug 28, 2024 | MRNA | $104.9K | Sale | 1,321 | $79.39 | Planned |
| Aug 28, 2024 | MRNA | $0 | Option Exercise | 329 | $N/A | Planned |
| Aug 27, 2024 | MRNA | $0 | Option Exercise | 1,326 | $N/A | Planned |
| Aug 27, 2024 | MRNA | $0 | Option Exercise | 1,326 | $N/A | Planned |
| Jul 8, 2024 | MRNA | $81.5K | Sale | 689 | $118.24 | Planned |
| Jul 5, 2024 | MRNA | $0 | Option Exercise | 1,452 | $N/A | Planned |
| Jun 3, 2024 | MRNA | $97.2K | Sale | 691 | $140.72 | Planned |
| May 31, 2024 | MRNA | $0 | Option Exercise | 1,326 | $N/A | Planned |
| May 29, 2024 | MRNA | $26.4K | Sale | 183 | $144.50 | Planned |
| May 28, 2024 | MRNA | $105.3K | Sale | 648 | $162.47 | Planned |
| May 28, 2024 | MRNA | $0 | Option Exercise | 328 | $N/A | Planned |
| May 24, 2024 | MRNA | $0 | Option Exercise | 1,326 | $N/A | Planned |
| Apr 8, 2024 | MRNA | $71.9K | Sale | 705 | $101.93 | Planned |
| Apr 5, 2024 | MRNA | $0 | Option Exercise | 1,453 | $N/A | Planned |
| Feb 29, 2024 | MRNA | $61.2K | Sale | 647 | $94.57 | Planned |